15089772

Source:http://linkedlifedata.com/resource/pubmed/id/15089772

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023449, umls-concept:C0439661, umls-concept:C0683598, umls-concept:C0939537, umls-concept:C1707810
pubmed:issue	4
pubmed:dateCreated	2004-4-19
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8703985
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Asparaginase, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0902-4441
pubmed:author	pubmed-author:AmabileMarilinaM, pubmed-author:BaccaraniMicheleM, pubmed-author:GaitaniStavroulaS, pubmed-author:MalagolaMicheleM, pubmed-author:MartinelliGiovanniG, pubmed-author:PaoliniStefaniaS, pubmed-author:PiccalugaPier PaoloPP, pubmed-author:RondoniMichelaM, pubmed-author:SoveriniSimonaS, pubmed-author:VisaniGiuseppeG
pubmed:issnType	Print
pubmed:volume	72
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	302-3
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15089772-Adult, pubmed-meshheading:15089772-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15089772-Asparaginase, pubmed-meshheading:15089772-Doxorubicin, pubmed-meshheading:15089772-Drug Resistance, Neoplasm, pubmed-meshheading:15089772-Fusion Proteins, bcr-abl, pubmed-meshheading:15089772-Humans, pubmed-meshheading:15089772-Male, pubmed-meshheading:15089772-Neoplasm Proteins, pubmed-meshheading:15089772-Neoplasm Recurrence, Local, pubmed-meshheading:15089772-Piperazines, pubmed-meshheading:15089772-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:15089772-Prednisone, pubmed-meshheading:15089772-Pyrimidines, pubmed-meshheading:15089772-Remission Induction, pubmed-meshheading:15089772-Stem Cell Transplantation, pubmed-meshheading:15089772-Transplantation, Homologous, pubmed-meshheading:15089772-Vincristine
pubmed:year	2004
pubmed:articleTitle	Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
pubmed:publicationType	Letter, Case Reports, Research Support, Non-U.S. Gov't